Find Research Outputs

Search results

• 2011

  A genome-wide association study identifies potential susceptibility Loci for hepatotoxicity due to various drugs

  Urban, T., Shen, Y., Chalasani, N. P., Fontana, R. J., Rochon, J., Stolz, A., Serrano, J. A., Aithal, G. P., Daly, A., Dillon, J. F., Floraros, A., Molokhia, M., Lucena, M. I., Goldstein, D. B. & Watkins, P. B., May 2011, In: Gastroenterology. 140, 5 Suppl. 1, p. S886-S886 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota

  Steed, H., Macfarlane, G. T., Blackett, K. L., Macfarlane, S., Miller, M. H., Bahrami, B. & Dillon, J. F., Dec 2011, In: FEMS Immunology and Medical Microbiology. 63, 3, p. 346-354 9 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)

• Barrett's esophagus: proton pump inhibitors and chemoprevention I

  Triadafilopoulos, G., Taddei, A., Bechi, P., Freschi, G., Ringressi, M. N., Degli'Innocenti, D. R., Castiglione, F., Masini, E., Majewski, M., Wallner, G., Sarosiek, J., Dillon, J. F., Mccallum, R. C., Dvorak, K., Goldman, A., Woodland, P., Sifrim, D., Richter, J. E., Vieth, M., Neumann, H. & 4 others, Langner, C., Ishimura, N., Amano, Y. & Felix, V. N., Sep 2011, In: Annals of the New York Academy of Sciences. 1232, 1, p. 93-113 21 p.

  Research output: Contribution to journal › Article › peer-review

  • Chemoprevention
  • Barrett Esophagus
  • Proton Pump Inhibitors
  • Normalization
  • Therapy
  2 Citations (Scopus)

• Does geographic access to primary healthcare influence the detection of hepatitis C?

  Astell-Burt, T., Flowerdew, R., Boyle, P. J. & Dillon, J. F., 2011, In: Social Science and Medicine. 72, 9, p. 1472-1481 10 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)

• Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care

  Innes, H. A., Hutchinson, S. J., Allen, S. H., Bhattacharyya, D., Bramley, P., Delahooke, T. E. S., Dillon, J. F., Forrest, E., Fraser, A., Gillespie, R., Goldberg, D. J., Kennedy, N., McDonald, S., McLeod, A., Mills, P. R., Morris, J. & Hayes, P., Nov 2011, In: Hepatology. 54, 5, p. 1547-1558

  Research output: Contribution to journal › Article › peer-review
  55 Citations (Scopus)

• Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006

  McDonald, S. A., Hutchinson, S. J., Bird, S. M., Mills, P. R., Hayes, P., Dillon, J. F. & Goldberg, D. J., 2011, In: Epidemiology and Infection. 139, 3, p. 344-353 10 p.

  Research output: Contribution to journal › Article › peer-review
  14 Citations (Scopus)

• Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection

  McDonald, S. A., Hutchinson, S. J., Bird, S. M., Robertson, C., Mills, P. R., Dillon, J. F. & Goldberg, D. J., Jan 2011, In: International Journal of Drug Policy. 22, 1, p. 63-69 7 p.

  Research output: Contribution to journal › Article › peer-review
  5 Citations (Scopus)

• Is it worth testing unstable drug users for Hepatitis C?

  Stephens, B. P., Tait, J. & Dillon, J. F., Oct 2011, In: Hepatology. 54, S1, p. 844A-844A 1 p.

  Research output: Contribution to journal › Special issue › peer-review
  1 Citation (Scopus)

• Novel non-invasive scoring system for the detection of NASH from a NAFLD population

  Miller, M., Jafferbhoy, H., Crowther, D., Walsh, S., Ferguson, M. A. & Dillon, J. F., Oct 2011, In: Hepatology. 54, p. 1113A-1113A 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
  1 Citation (Scopus)

• Predictors of neoplasia in patients presenting with obstructive jaundice

  Smith, A., Miller, M., Groome, M. & Dillon, J. F., Oct 2011, In: Hepatology. 54, S1, p. 1423A-1424A 2 p.

  Research output: Contribution to journal › Special issue › peer-review
  1 Citation (Scopus)

• Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR

  Jafferbhoy, H., Miller, M. H., El Wahed, Z. & Dillon, J. F., 2011, In: Journal of Hepatology. 55, 5, p. 1162-1164 3 p.

  Research output: Contribution to journal › Letter › peer-review
  5 Citations (Scopus)

• Response and predictors of response, to pegylated interferon and ribavirin for chronic hepatitis C patients in Scotland: alanine aminotransferase (ALT) and gamma glutamyl transferase (GGT) are valuable pre-treatment markers of an SVR in routine clinical practice

  Innes, H., Hutchinson, S., Allen, S., Bhattacharyya, D., Bramley, P., Carman, B., Delahooke, T., Dillon, J., Goldberg, D., Kennedy, N., Mills, P., Morris, J., Stanley, A. & Hayes, P., 2011, In: Journal of Epidemiology and Community Health. 65, Supplement 1, p. A254 1 p., P2-122.

  Research output: Contribution to journal › Meeting abstract › peer-review
  20 Citations (Scopus)

• Spontaneous bacterial peritonitis prophylaxis: reducing the incidence of hospital acquired infection

  Jafferbhoy, H., Miller, M., Shekar, C. C., Lockhart, M. & Dillon, J. F., Oct 2011, In: Hepatology. 54, S1, p. 1239A-1240A 2 p.

  Research output: Contribution to journal › Special issue › peer-review
  1 Citation (Scopus)

• Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles

  Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz-Cabello, F., Donaldson, P. T., Stephens, C., Pirmohamed, M., Romero-Gomez, M., Navarro, J. M., Fontana, R. J., Miller, M., Groome, M., Bondon-Guitton, E., Conforti, A., Stricker, B. H. C., Carvajal, A. & 12 others, Ibanez, L., Yue, Q-Y., Eichelbaum, M., Floratos, A., Pe'er, I., Daly, M. J., Goldstein, D. B., Dillon, J. F., Nelson, M. R., Watkins, P. B., Daly, A. K. & Int SAEC, EUDRAGENE, Spanish DILI Registry, DILIGEN, DILIN, 2011, In: Gastroenterology. 141, 1, p. 338-347 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  309 Citations (Scopus)

• Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease

  Miller, M. H., Ferguson, M. A. J. & Dillon, J. F., Apr 2011, In: Liver International. 31, 4, p. 461-473 13 p.

  Research output: Contribution to journal › Review article › peer-review
  37 Citations (Scopus)

• The development and external validation of a model to predict one year all-cause mortality following liver function tests in primary care patients

  McLernon, D. J., Dillon, J. F. & Donnan, P. T., 2011, In: Value in Health. 14, 7, p. A392 1 p.

  Research output: Contribution to journal › Article › peer-review

• The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow

  McDonald, S., Hutchinson, S., Mills, P., Bird, S., Cameron, S., Dillon, J. & Goldberg, D., 2011, In: Journal of Epidemiology and Community Health. 65, p. A271 1 p.

  Research output: Contribution to journal › Book/Film/Article review › peer-review

• The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population

  McDonald, S. A., Hutchinson, S. J., Mills, P. R., Bird, S. M., Cameron, S., Dillon, J. F. & Goldberg, D. J., 2011, In: Journal of Viral Hepatitis. 18, 4, p. e126-e133 8 p.

  Research output: Contribution to journal › Article › peer-review
  13 Citations (Scopus)
• 2014

  Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan

  Mcdonald, S. A., Hutchinson, S. J., Innes, H. A., Allen, S., Bramley, P., Bhattacharyya, D., Carman, W., Dillon, J. F., Fox, R., Fraser, A., Goldberg, D. J., Kennedy, N., Mills, P. R., Morris, J., Stanley, A. J., Wilks, D. & Hayes, P. C., May 2014, In: Journal of Viral Hepatitis. 21, 5, p. 366-376 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Scotland
  • Hepatitis C
  • Hepatitis
  • Antiviral Agents
  • Ambulatory Care Facilities
  15 Citations (Scopus)

• Commentary: real-world triple therapy experience treating hepatitis C virus

  Heron, T., Miller, M. H. & Dillon, J. F., Mar 2014, In: Alimentary Pharmacology & Therapeutics. 39, 5, p. 542 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Citation (Scopus)

• Commentary: Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B

  Miller, M., Heron, T. & Dillon, J., 2014, In: Alimentary Pharmacology & Therapeutics. 39, 10, p. 1236 12704.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Disorders of the liver

  Polignano, F. M., Dillon, J. F., Zealley, I. A., Quyn, A. J., Smith, A. & Cuschieri, S. A., 28 Nov 2014, Essential Surgical Practice: Higher Surgical Training in General Surgery. Cuschieri, A. & Hanna, G. (eds.). 5 ed. London: CRC Press, p. 616-670 55 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Round Ligaments
  • Liver
  • Veins
  • Portal System
  • Yolk Sac
  1 Citation (Scopus)

• Eradicating hepatitis C is a realistic aim

  Ryder, S. & Dillon, J., 9 May 2014, In: Health Service Journal. 124, 6397, p. 21-23 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model

  Innes, H., Goldberg, D., Dusheiko, G., Hayes, P., Mills, P. R., Dillon, J. F., Aspinall, E., Barclay, S. T. & Hutchinson, S. J., 2014, In: Journal of Hepatology. 60, 6, p. 1118-1126 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepacivirus
  • Liver Failure
  • Liver Diseases
  • Fibrosis
  • Patient Simulation
  15 Citations (Scopus)

• Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts

  McLernon, D. J., Donnan, P. T., Sullivan, F. M., Roderick, P., Rosenberg, W. M., Ryder, S. D. & Dillon, J. F., 2 Jun 2014, In: BMJ Open. 4, 6, 10 p., e004837.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Function Tests
  • Liver Diseases
  • Primary Health Care
  • Population
  • Scotland
  11 Citations (Scopus)

  200 Downloads (Pure)

• Proteomic and genomic studies of non-alcoholic fatty liver disease - clues in the pathogenesis

  Lim, J. W., Dillon, J. & Miller, M., 14 Jul 2014, In: World Journal of Gastroenterology . 20, 26, p. 8325-8340 16 p.

  Research output: Contribution to journal › Article › peer-review

  • Non-alcoholic Fatty Liver Disease
  • Proteomics
  • Liver
  • Fibrosis
  • Acute-Phase Reaction
  28 Citations (Scopus)

• Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy

  Miller, M. H., Agarwal, K., Austin, A., Brown, A., Barclay, S. T., Dundas, P., Dusheiko, G. M., Foster, G. R., Fox, R., Hayes, P. C., Leen, C., Millson, C., Ryder, S. D., Tait, J., Ustianowski, A. & Dillon, J. F., Jun 2014, In: Alimentary Pharmacology & Therapeutics. 39, 12, p. 1363-1375 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepatitis C
  • Consensus
  • Hepacivirus
  • Guidelines
  • Chronic Hepatitis C
  36 Citations (Scopus)

• Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes, but not with insulin resistance

  Meakin, P. J., Chowdhry, S., Sharma, R. S., Ashford, F. B., Walsh, S. V., McCrimmon, R. J., Dinkova-Kostova, A. T., Dillon, J. F., Hayes, J. D. & Ashford, M. L. J., Sep 2014, In: Molecular and Cellular Biology. 34, 17, p. 3305-3320 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • NF-E2-Related Factor 2
  • Unfolded Protein Response
  • Fatty Liver
  • High Fat Diet
  • Insulin Resistance
  105 Citations (Scopus)

  315 Downloads (Pure)

• The serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis

  Miller, M. H., Walsh, S. V., Atirh, A., Huang, J. T-J., Ferguson, M. A. J. & Dillon, J. F., Oct 2014, In: Journal of Gastroenterology and Hepatology. 29, 10, p. 1839-1847 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Non-alcoholic Fatty Liver Disease
  • Proteome
  • Biomarkers
  • Serum
  • Proteomics
  23 Citations (Scopus)

• Update on the treatment of hepatitis C genotypes 2-6

  Paterson, J. C. M., Miller, M. H. & Dillon, J. F., Dec 2014, In: Current Opinion in Infectious Diseases. 27, 6, p. 540-544 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepatitis C
  • Genotype
  • Antiviral Agents
  • Global Health
  • Interferons
  5 Citations (Scopus)

• Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland

  McAllister, G., Innes, H., Mcleod, A., Dillon, J. F., Hayes, P. C., Fox, R., Barclay, S. T., Templeton, K., Aitken, C., Gunson, R., Goldberg, D. & Hutchinson, S. J., Nov 2014, In: Journal of Clinical Virology . 61, 3, p. 359-364 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Scotland
  • Hepatitis C
  • Specimen Handling
  • Pharmaceutical Preparations
  • Phlebotomy
  28 Citations (Scopus)
• 2016

  A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

  Aspinall, E. J., Mitchell, W., Schofield, J., Cairns, A., Lamond, S., Bramley, P., Peters, S. E., Valerio, H., Tomnay, J., Goldberg, D. J., Mills, P. R., Barclay, S. T., Fraser, A., Dillon, J. F., Martin, N. K., Hickman, M. & Hutchinson, S. J., Dec 2016, In: Journal of Viral Hepatitis. 23, 12, p. 1009-1016 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Prisons
  • Hepatitis C
  • Prisoners
  • Therapeutics
  • Antiviral Agents
  28 Citations (Scopus)

  190 Downloads (Pure)

• Gamma glutamyl transferase "To be or not to be" a Liver function test?

  Dillon, J. F. & Miller, M. H., 1 Nov 2016, In: Annals of Clinical Biochemistry. 53, 6, p. 629-631 3 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

  File
  3 Citations (Scopus)

  216 Downloads (Pure)

• Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs

  Weir, A., McLeod, A., Innes, H., Valerio, H., Aspinall, E. J., Goldberg, D. J., Barclay, S. T., Dillon, J. F., Fox, R., Fraser, A., Hayes, P. C., Kennedy, N., Mills, P. R., Stanley, A. J., Aitken, C., Gunson, R., Templeton, K., Hunt, A., McIntyre, P. & Hutchinson, S. J., 1 Aug 2016, In: Drug and Alcohol Dependence. 165, p. 53-60 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Viruses
  • Hepacivirus
  • Pharmaceutical Preparations
  • RNA
  29 Citations (Scopus)

  288 Downloads (Pure)

• MAIT cells are activated during human viral infections

  Van Wilgenburg, B., Scherwitzl, I., Hutchinson, E. C., Leng, T., Kurioka, A., Kulicke, C., De Lara, C., Cole, S., Vasanawathana, S., Limpitikul, W., Malasit, P., Young, D., Denney, L., Moore, M. D., Fabris, P., Giordani, M. T., Oo, Y. H., Laidlaw, S. M., Dustin, L. B., Ho, L. P. & 35 others, Thompson, F. M., Ramamurthy, N., Mongkolsapaya, J., Willberg, C. B., Screaton, G. R., Klenerman, P., Barnes, E., Ball, J., Burgess, G., Cooke, G., Dillon, J., Gore, C., Foster, G., Guha, N., Halford, R., Herath, C., Holmes, C., Howe, A., Hudson, E., Irving, W., Khakoo, S., Koletzki, D., Martin, N., Mbisa, T., McKeating, J., McLauchlan, J., Miners, A., Murray, A., Shaw, P., Simmonds, P., Spencer, C., Targett-Adams, P., Thomson, E., Vickerman, P. & Zitzmann, N., 23 Jun 2016, In: Nature Communications. 7, 11653.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Mucosal-Associated Invariant T Cells
  • T-cells
  • infectious diseases
  • Virus Diseases
  • activation
  188 Citations (Scopus)

  292 Downloads (Pure)

• Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication

  Leask, J. D. & Dillon, J. F., Jul 2016, In: Alimentary Pharmacology & Therapeutics. 44, 2, p. 145-156 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Hepacivirus
  • Pharmaceutical Preparations
  • Therapeutics
  • Prisoners
  10 Citations (Scopus)

  166 Downloads (Pure)

• 'Standing Outside the Junkie Door'-service users' experiences of using community pharmacies to access treatment for opioid dependency

  Radley, A., Melville, K., Easton, P., Williams, B. & Dillon, J. F., Dec 2016, In: Journal of Public Health. 39, 4, p. 846-855 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmacies
  • Dependency (Psychology)
  • Opioid Analgesics
  • Opiate Substitution Treatment
  • Respect
  7 Citations (Scopus)

  191 Downloads (Pure)

• The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α

  Orr, J. G., Currie, C. J., Berni, E., Goel, A., Moriarty, K. J., Sinha, A., Gordon, F., Dethier, A., Dillon, J., Clark, K., Richardson, P., Middleton, P., Patel, V., Shawcross, D., Preedy, H., Aspinall, R. J. & Hudson, M., Sep 2016, In: Liver International. 36, 9, p. 1295-1303 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Rifaximin
  • Hepatic Encephalopathy
  • Length of Stay
  • Drug Costs
  • Therapeutics
  26 Citations (Scopus)

  182 Downloads (Pure)

• The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large ‘real world’ cohort

  Wang, H., Innes, H., Hutchinson, S. J., Goldberg, D. J., Allen, S., Barclay, S. T., Bramley, P., Fox, R., Fraser, A., Hayes, P. C., Kennedy, N., Mills, P. R. & Dillon, J. F., Apr 2016, In: European Journal of Gastroenterology & Hepatology. 28, 4, p. 398-404 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Leukopenia
  • Hepatitis C
  • Thrombocytopenia
  • Anemia
  • Therapeutics
  1 Citation (Scopus)
• 2018

  Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

  Cunningham, E. B., Amin, J., Feld, J. J., Bruneau, J., Dalgard, O., Powis, J., Hellard, M., Cooper, C., Read, P., Conway, B., Dunlop, A. J., Norton, B., Litwin, A. H., Hajarizadeh, B., Thurnheer, M. C., Dillon, J. F., Weltman, M., Shaw, D., Bruggmann, P., Gane, E. & 8 others, Fraser, C., Marks, P., Applegate, T. L., Quiene, S., Siriragavan, S., Matthews, G. V., Dore, G. J. & Grebely, J., Dec 2018, In: International Journal of Drug Policy. 62, p. 14-23 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • velpatasvir
  • Sofosbuvir
  • Injections
  • Infection
  • Pharmaceutical Preparations
  21 Citations (Scopus)

  66 Downloads (Pure)

• Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial

  Radley, A., de Bruin, M., Inglis, S. K., Donnan, P. T. & Dillon, J. F., 14 Dec 2018, In: BMJ Open. 8, 12, p. 1-8 8 p., e021443.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Pharmacy
  • Pharmacists
  • Hepacivirus
  7 Citations (Scopus)

  157 Downloads (Pure)

• Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease

  Spanos, C., Maldonado, E. M., Fisher, C. P., Leenutaphong, P., Oviedo-Orta, E., Windridge, D., Salguero, F. J., Bermúdez-Fajardo, A., Weeks, M. E., Evans, C., Corfe, B. M., Rabbani, N., Thornalley, P. J., Miller, M. H., Wang, H., Dillon, J. F., Quaglia, A., Dhawan, A., Fitzpatrick, E. & Moore, J. B., 25 Jun 2018, In: Proteome Science. 16, 13, p. 13 1 p., 13.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  File

  • Proteomics
  • Liver
  • Non-alcoholic Fatty Liver Disease
  123 Downloads (Pure)

• Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes

  Miller, M. H., Fraser, A., Leggett, G., MacGilchrist, A., Gibson, G., Orr, J., Forrest, E. H., Dow, E., Bartlett, W., Weatherburn, C., Laurell, A., Grant, K., Scott, K., Neville, R. & Dillon, J. F., Jul 2018, In: Frontline Gastroenterology. 9, 3, p. 175-182 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Function Tests
  • Triage
  • Liver Diseases
  • Datasets
  • Primary Health Care
  3 Citations (Scopus)

  257 Downloads (Pure)

• Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Armstrong, I., Baker, A., Bhala, N., Camps-Walsh, G., Cramp, M. E., de Lusignan, S., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G., Gilmore, I., Hudson, M., Kelly, D., Langford, A., McDougall, N., Meier, P. & 14 others, Moriarty, K., Newsome, P., O'Grady, J., Pryke, R., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Taylor, A., Thompson, J., Thorburn, D., Verne, J., Wass, J. & Yeoman, A., 17 Mar 2018, In: Lancet. 391, 10125, p. 1097-1107 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Cost of Illness
  • Hepatitis
  • Industry
  • Alcohol Drinking
  • Liver Diseases
  62 Citations (Scopus)

  545 Downloads (Pure)

• Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD

  Brennan, P. N. & Dillon, J. F., Jan 2018, In: Alimentary Pharmacology & Therapeutics. 47, 2, p. 299-300 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2)

  Sharma, R. S., Harrison, D. J., Kisielewski, D., Cassidy, D. M., McNeilly, A. D., Gallagher, J. R., Walsh, S. V., Honda, T., McCrimmon, R. J., Dinkova-Kostova, A. T., Ashford, M. L. J., Dillon, J. F. & Hayes, J. D., 1 Mar 2018, In: CMGH: Cellular and Molecular Gastroenterology and Hepatology. 5, 3, p. 367-398 32 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • TBE 31
  • NF-E2-Related Factor 2
  • Fructose
  • Non-alcoholic Fatty Liver Disease
  • Liver Cirrhosis
  62 Citations (Scopus)

  168 Downloads (Pure)

• Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Aspinall, R., Batterham, R., Bhala, N., Bosanquet, N., Severi, K., Burton, A., Burton, R., Cramp, M. E., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G. R., Gilmore, I., Greenberg, J., Henn, C., Hudson, M. & 18 others, Jarvis, H., Kelly, D., Mann, J., McDougall, N., McKee, M., Moriarty, K., Morling, J., Newsome, P., O'Grady, J., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Thorburn, D., Verne, J., Vohra, J., Wass, J. & Yeoman, A., 1 Dec 2018, In: Lancet. 392, 10162, p. 2398-2412 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Diseases
  • Alcohols
  • National Health Programs
  • Obesity
  • England
  28 Citations (Scopus)

  444 Downloads (Pure)

• Guidelines on the management of abnormal liver blood tests

  Newsome, P. N. G., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., Mackie, A., Mitchell-Thain, R., Sennett, K., Sheron, N. C., Verne, J., Walmsley, M. & Yeoman, A., Jan 2018, In: Gut. 67, 1, p. 6-19 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hematologic Tests
  • Guidelines
  • Gastroenterology
  • Liver
  • Biochemistry
  82 Citations (Scopus)

  207 Downloads (Pure)

• Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings: what is required to achieve the WHO's HCV elimination targets?

  Ward, Z., Platt, L., Sweeney, S., Hope, V. D., Maher, L., Hutchinson, S., Palmateer, N., Smith, J., Craine, N., Taylor, A., Martin, N., Ayres, R., Dillon, J., Hickman, M. & Vickerman, P., Sep 2018, In: Addiction. 113, 9, p. 1727-1738 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Hepacivirus
  • Pharmaceutical Preparations
  • Syringes
  16 Citations (Scopus)

  136 Downloads (Pure)

• Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis

  Wang, H., Swann, R., Thomas, E., Innes, H. A., Valerio, H., Hayes, P. C., Allen, S., Barclay, S. T., Wilks, D., Fox, R., Bhattacharyya, D., Kennedy, N., Morris, J., Fraser, A., Stanley, A. J., Gunson, R., Mclntyre, P. G., Hunt, A., Hutchinson, S. J., Mills, P. R. & 1 others, Dillon, J. F., 1 Aug 2018, In: Journal of Viral Hepatitis. 25, 8, p. 930-938 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Chronic Hepatitis C
  • Hepatitis B
  • Hepacivirus
  • Hepatitis B virus
  • Liver
  5 Citations (Scopus)

  146 Downloads (Pure)